From Nasdaq:



Validea’s guru fundamental report for BIOMARIN PHARMACEUTICAL INC (BMRN) rates the stock the highest using the Value Investor model based on the strategy of Benjamin Graham. This methodology looks for stocks with low P/B and P/E ratios, low debt, and solid long-term earnings growth. BMRN received a 57% rating based on the firm’s underlying fundamentals and the stock’s valuation.

The stock meets several criteria such as sector, sales, and current ratio, but fails in long-term EPS growth and P/E ratio. Benjamin Graham, known as the “Father of Value Investing”, had a significant impact on the investing world and inspired many other successful investors, including Warren Buffett.

Validea is an investment research service that follows the published strategies of investment legends like Warren Buffett and Benjamin Graham. For more information about Validea, visit their website. The guru fundamental report provides valuable insight for investors considering BIOMARIN PHARMACEUTICAL INC (BMRN) as a potential investment.



Read more: Benjamin Graham Detailed Fundamental Analysis – BMRN